EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:31058 - (13R)-13-dihydrocarminomycin
| Formula | C26H29NO10 |
| Net Charge | 0 |
| Average Mass | 515.515 |
| Monoisotopic Mass | 515.17915 |
| SMILES | C[C@@H]1O[C@@H](O[C@H]2C[C@](O)([C@@H](C)O)Cc3c(O)c4c(c(O)c32)C(=O)c2c(O)cccc2C4=O)C[C@H](N)[C@@H]1O |
| InChI | InChI=1S/C26H29NO10/c1-9-21(30)13(27)6-16(36-9)37-15-8-26(35,10(2)28)7-12-18(15)25(34)20-19(23(12)32)22(31)11-4-3-5-14(29)17(11)24(20)33/h3-5,9-10,13,15-16,21,28-30,32,34-35H,6-8,27H2,1-2H3/t9-,10+,13-,15-,16-,21+,26-/m0/s1 |
| InChIKey | YXBSCYMMPXQFDS-LBIZDXDESA-N |
| Roles Classification |
|---|
| Biological Roles: | cardiotoxic agent A role played by a chemical compound exhibiting itself through the ability to induce damage to the heart and cardiomyocytes. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has functional parent carminomycin (CHEBI:31359) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has parent hydride tetracene (CHEBI:32600) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has role antineoplastic agent (CHEBI:35610) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has role cardiotoxic agent (CHEBI:50912) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has role drug metabolite (CHEBI:49103) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) is a p-quinones (CHEBI:25830) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) is a aminoglycoside antibiotic (CHEBI:22507) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) is a anthracycline antibiotic (CHEBI:49322) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) is a tetracenequinones (CHEBI:51286) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) is conjugate base of (13R)-13-dihydrocarminomycin(1+) (CHEBI:140330) |
| Incoming Relation(s) |
| (13R)-13-dihydrocarminomycin(1+) (CHEBI:140330) is conjugate acid of (13R)-13-dihydrocarminomycin (CHEBI:31058) |
| IUPAC Name |
|---|
| (1S,3S)-3,5,10,12-tetrahydroxy-3-[(1R)-1-hydroxyethyl]-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| Synonyms | Source |
|---|---|
| Dihydrokarminomycin | ChemIDplus |
| Carminomycinol | ChemIDplus |
| RP-32999 | ChemIDplus |
| Antibiotic 32999RP | ChemIDplus |
| Dihydrocarminomycin | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| CAS:62182-86-9 | KEGG COMPOUND |
| CAS:62182-86-9 | ChemIDplus |
| Citations |
|---|